Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1433)
  3. Review (81)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3387)
  2. Solid Tumor Oncology Division (3387)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (636)
  3. Gregory Riely (604)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (107)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (701)
  2. Journal of Thoracic Oncology (514)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (780)
  2. Elsevier Inc. (735)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3387)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ORCHARD: Osimertinib plus necitumumab in patients with epidermal growth factor receptor–mutated advanced non–small cell lung cancer with a secondary epidermal growth factor receptor alteration whose disease had progressed on first-line osimertinib
    Journal Article

    Riess, J. W.; de Langen, A. J.; Ponce, S.; Goldberg, S. B.; Piotrowska, Z.; Goldman, J. W.; Le, X.; Cho, B. C.; Yoneshima, Y.; Ambrose, H.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Lung cancer and cardiovascular disease: Common pathophysiology and treatment-emergent toxicity
    Review

    El-Rayes, M.; Nardi Agmon, I.; Yu, C.; Osataphan, N.; Yu, H. A.; Hope, A.; Sacher, A.; Yu, A. F.; Abdel-Qadir, H.; Thavendiranathan, P.
    JACC: CardioOncology (2025)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer
    Journal Article

    Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
    Journal Article

    Febres-Aldana, C. A.; Vojnic, M.; Odintsov, I.; Zhang, T.; Cheng, R.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A. M.; Gili, L.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Selpercatinib in RET fusion-positive non-small cell lung cancer: Final safety and efficacy, including overall survival, from the LIBRETTO-001 phase I/II trial
    Journal Article

    Gautschi, O.; Park, K.; Solomon, B. J.; Tomasini, P.; Loong, H. H.; De Braud, F.; Goto, K.; Peterson, P.; Barker, S.; Liming, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with stereotactic radiosurgery
    Journal Article

    Gaeta, B.; Eichholz, J. E.; Walch, H.; Ilica, A. T.; Boe, L.; Kratochvil, L.; Yu, Y.; Gomez, D. R.; Imber, B. S.; Li, B. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients
    Journal Article

    Barrichello, A. P. C.; Elkrief, A.; Ricciuti, B.; Ganta, T.; Marron, T. U.; Wang, X.; Lotter, W.; Lindsay, J.; Santo, V.; Cortellini, A.; more...
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Barriers to publishing early phase clinical trials: The oncologists’ perspective
    Journal Article

    Lucassen, M. J. J.; Bergmann, P.; Husson, O.; Banerji, U.; Basu, B.; Melero, I.; Calvo, E.; Cassier, P. A.; Drilon, A.; Fong, P. C.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Tumor-infiltrating clonal hematopoiesis
    Journal Article

    Pich, O.; Bernard, E.; Zagorulya, M.; Rowan, A.; Pospori, C.; Slama, R.; Huerga Encabo, H.; O'Sullivan, J.; Papazoglou, D.; Anastasiou, P.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save